Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retro-prospective Observational Study on Risk of Progression in Chronic Phase-Chronic Myeloid Leukemia Patients Eligible for Tyrosine Kinase Inhibitor Discontinuation (TFR - PRO)

NCT04621851 is registered in ClinicalTrials.gov with University of Milano Bicocca as lead sponsor.

NCT NCT04621851
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04621851 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retro-prospective Observational Study on Risk of Progression in Chronic Phase-Chronic Myeloid Leukemia Patients Eligible for Tyrosine Kinase Inhibitor Discontinuation (TFR - PRO)
Lead sponsor
University of Milano Bicocca
Phase
Observational
Overall status
Completed
Start date
September 30, 2020
Completion date
August 14, 2023
Enrollment
260 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloid leukemia